VTI.ASX: Business Activity Statement & Appendix 4C - Dec-2024 Qtr

Business Activity Statement & Appendix 4C - Dec-2024 Qtr

Stock	Visioneering Technologies Inc (VTI.ASX)
Release Time	31 Jan 2025, 9:49 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Visioneering Announces Q4 FY'24 Results

Key Points

Net Revenue: $1.8 million, down 4% from Q4 FY'23
Shipments to US ECPs: $1.9 million, up 6% from Q4 FY'23
Cash receipts from customers: $2.2 million, up 36% from Q4 FY'23

Full Summary

Visioneering Technologies Inc. (ASX:VTI), producer of the NaturalVue® Multifocal 1 Day Contact Lenses, announced its unaudited results for the quarter ended 31 December 2024. Net Revenue was $1.8 million, down 4% from Q4 FY'23, while Shipments to US ECPs were $1.9 million, up 6% from Q4 FY'23. Cash receipts from customers were $2.2 million, up 36% from Q4 FY'23. Net cash used in operating activities was $0.6 million, a 59% decrease compared to Q4 FY'23. Gross margin was 57.1%, up from 57.0% in Q4 FY'23. The company's PROTECT Randomized Clinical Trial showed sustained myopia progression control, and the NaturalVue® Multifocal 1 Day Contact Lense was recognized with the prestigious Optician Award in the UK. Visioneering continues to expand internationally, signing agreements for Europe, Vietnam, and South Korea.